Phenotyping of Sleep-Disordered Breathing in Patients With Chronic Heart Failure With Reduced Ejection Fraction-the SchlaHF Registry

Michael Arzt, Olaf Oldenburg, Andrea Graml, Erland Erdmann, Helmut Teschler, Karl Wegscheider, Anna Suling, Holger Woehrle, SchlaHF Investigators, Michael Arzt, Olaf Oldenburg, Andrea Graml, Erland Erdmann, Helmut Teschler, Karl Wegscheider, Anna Suling, Holger Woehrle, SchlaHF Investigators

Abstract

Background: Different sleep-disordered breathing (SDB) phenotypes, including coexisting obstructive and central sleep apnea (OSA-CSA), have not yet been characterized in a large sample of patients with heart failure and reduced ejection fraction (HFrEF) receiving guideline-based therapies. Therefore, the aim of the present study was to determine the proportion of OSA, CSA, and OSA-CSA, as well as periodic breathing, in HFrEF patients with SDB.

Methods and results: The German SchlaHF registry enrolled patients with HFrEF receiving guideline-based therapies, who underwent portable SDB monitoring. Polysomnography (n=2365) was performed in patients with suspected SDB. Type of SDB (OSA, CSA, or OSA-CSA), the occurrence of periodic breathing (proportion of Cheyne-Stokes respiration ≥20%), and blood gases were determined in 1557 HFrEF patients with confirmed SDB. OSA, OSA-CSA, and CSA were found in 29%, 40%, and 31% of patients, respectively; 41% showed periodic breathing. Characteristics differed significantly among SDB groups and in those with versus without periodic breathing. There was a relationship between greater proportions of CSA and the presence of periodic breathing. Risk factors for having CSA rather than OSA were male sex, older age, presence of atrial fibrillation, lower ejection fraction, and lower awake carbon dioxide pressure (pco2). Periodic breathing was more likely in men, patients with atrial fibrillation, older patients, and as left ventricular ejection fraction and awake pco2 decreased, and less likely as body mass index increased and minimum oxygen saturation decreased.

Conclusions: SchlaHF data show that there is wide interindividual variability in the SDB phenotype of HFrEF patients, suggesting that individualized management is appropriate.

Clinical trial registration: URL: https://www.clinicaltrials.gov/. Unique identifier: NCT01500759.

Keywords: heart failure; phenotypes; sleep apnea; sleep disorders.

© 2017 The Authors and ResMed Germany Inc. Published on behalf of the American Heart Association, Inc., by Wiley.

Figures

Figure 1
Figure 1
Patient populations and flow in the SchlaHF registry. AHI indicates apnea‐hypopnea index; CSR, Cheyne‐Stokes respiration; HFrEF, heart failure with reduced ejection fraction; NYHA, New York Heart Association; PSG, polysomnography; SDB, sleep‐disordered breathing. † SDB or typical clinical symptoms indicative of SDB. *Incomplete data included patients with no data on SDB screening (n=390), age (n=1), body mass index (BMI; n=1), left ventricular ejection fraction (LVEF; n=1946), NYHA class (n=1957), atrial fibrillation (n=1977), and etiology of HFrEF (patients could have more than 1 piece of data missing). The high number of missing values for BMI, LVEF, and NYHA was due to recording of these variables being introduced to the registry after a protocol change.
Figure 2
Figure 2
Prevalence of obstructive and central sleep apnea by sex. CSA indicates central sleep apnea (defined as cAHI/AHI ≥80%); OSA, obstructive sleep apnea (defined as cAHI/AHI 0% to 19.9%); OSA+CSA, obstructive sleep apnea+central sleep apnea (defined as cAHI/AHI 20% to 79.9%). AHI indicates apnea‐hypopnea index; cAHI, central AHI.
Figure 3
Figure 3
Prevalence of periodic breathing (defined as Cheyne‐Stokes respiration [CSR] ≥20%) according to sleep apnea type. CSA indicates central sleep apnea (defined as cAHI/AHI ≥80.0%); OSA, obstructive sleep apnea (defined as cAHI/AHI 0% to 19.9%); OSA+CSA, obstructive sleep apnea+central sleep apnea (defined as cAHI/AHI 20% to 79.9%). AHI indicates apnea‐hypopnea index; cAHI, central AHI.
Figure 4
Figure 4
Forest plot of risk factors for central sleep apnea (higher cAHI/AHI percentage) and obstructive sleep apnea (lower cAHI/AHI percentage). AHI indicates apnea‐hypopnea index; BMI, body mass index; cAHI, central AHI; CI, confidence interval; LVEF, left ventricular ejection fraction; min, minimum; NYHA, New York Heart Association; pco 2, partial pressure of carbon dioxide; Sao 2, oxygen saturation.
Figure 5
Figure 5
Forest plot of risk factors for periodic breathing (defined as Cheyne‐Stokes respiration [CSR] ≥20%). AHI indicates apnea‐hypopnea index; BMI, body mass index; cAHI, central AHI; CI, confidence interval; LVEF, left ventricular ejection fraction; min, minimum; NYHA, New York Heart Association; pco 2, partial pressure of carbon dioxide; Sao 2, oxygen saturation.

References

    1. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004;43:317–327.
    1. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93:1137–1146.
    1. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD. Resource utilization among congestive heart failure study. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol. 2002;39:60–69.
    1. Roger VL, Go AS, Lloyd‐Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee . Heart disease and stroke statistics—2012 update: a report from the American Heart association. Circulation. 2012;125:e2–e220.
    1. Roger VL. Epidemiology of heart failure. Circ Res. 2013;113:646–659.
    1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez‐Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines . ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787–1847.
    1. Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V. Sleep‐disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail. 2007;9:251–257.
    1. Schulz R, Blau A, Borgel J, Duchna HW, Fietze I, Koper I, Prenzel R, Schadlich S, Schmitt J, Tasci S, Andreas S. Sleep apnoea in heart failure. Eur Respir J. 2007;29:1201–1205.
    1. Arzt M, Woehrle H, Oldenburg O, Graml A, Suling A, Erdmann E, Teschler H, Wegscheider K; SchlaHF Investigators . Prevalence and predictors of sleep‐disordered breathing in patients with stable chronic heart failure: the SchlaHF registry. JACC Heart Fail. 2016;4:116–125.
    1. Ryan CM, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson KA, Belenkie I, Pfeifer M, Fleetham J, Hanly PJ, Smilovitch M, Arzt M, Bradley TD; CANPAP Investigators . Shift in sleep apnoea type in heart failure patients in the CANPAP trial. Eur Respir J. 2010;35:592–597.
    1. Bitter T, Westerheide N, Prinz C, Hossain MS, Vogt J, Langer C, Horstkotte D, Oldenburg O. Cheyne‐Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter‐defibrillator therapies in patients with congestive heart failure. Eur Heart J. 2011;32:61–74.
    1. Hanly PJ, Zuberi‐Khokhar NS. Increased mortality associated with Cheyne‐Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med. 1996;153:272–276.
    1. Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol. 2007;49:2028–2034.
    1. Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, Giannuzzi P. Prognostic value of nocturnal Cheyne‐Stokes respiration in chronic heart failure. Circulation. 1999;99:1435–1440.
    1. Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, Ruttanaumpawan P, Tomlinson G, Bradley TD. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49:1625–1631.
    1. Yumino D, Wang H, Floras JS, Newton GE, Mak S, Ruttanaumpawan P, Parker JD, Bradley TD. Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail. 2009;15:279–285.
    1. Yumino D, Kasai T, Kimmerly D, Amirthalingam V, Floras JS, Bradley TD. Differing effects of obstructive and central sleep apneas on stroke volume in patients with heart failure. Am J Respir Crit Care Med. 2013;187:433–438.
    1. Cowie MR, Woehrle H, Wegscheider K, Angermann C, d'Ortho MP, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H. Adaptive servo‐ventilation for central sleep apnea in systolic heart failure. N Engl J Med. 2015; 373:1095–1105.
    1. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol. 2006;106:21–28.
    1. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, Roselle GA. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97:2154–2159.
    1. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne‐Stokes respiration. Circulation. 2000;102:61–66.
    1. Tkacova R, Niroumand M, Lorenzi‐Filho G, Bradley TD. Overnight shift from obstructive to central apneas in patients with heart failure: role of pco 2 and circulatory delay. Circulation. 2001;103:238–243.
    1. Woehrle H, Oldenburg O, Arzt M, Graml A, Erdmann E, Teschler H, Wegscheider K; SCHLA‐HF Investigators . Determining the prevalence and predictors of sleep disordered breathing in patients with chronic heart failure: rationale and design of the SCHLA‐HF registry. BMC Cardiovasc Disord. 2014;14:46.
    1. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Levy S, Linde C, Lopez‐Sendon JL, Nieminen MS, Pierard L, Remme WJ. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115–1140.
    1. Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP; Davidson Ward SL; Tangredi MM; American Academy of Sleep Medicine . Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8:597–619.
    1. Randerath WJ, Treml M, Priegnitz C, Stieglitz S, Hagmeyer L, Morgenstern C. Evaluation of a noninvasive algorithm for differentiation of obstructive and central hypopneas. Sleep. 2013;36:363–368.
    1. Won C, Guilleminault C. Gender differences in sleep disordered breathing: implications for therapy. Expert Rev Respir Med. 2015;9:221–231.
    1. McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, Mediano O, Chen R, Drager LF, Liu Z, Chen G, Du B, McArdle N, Mukherjee S, Tripathi M, Billot L, Li Q, Lorenzi‐Filho G, Barbe F, Redline S, Wang J, Arima H, Neal B, White DP, Grunstein RR, Zhong N, Anderson CS; SAVE Investigators and Coordinators . CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375:919–931.

Source: PubMed

3
Abonneren